GelSana awarded $1.25M AFWERX Phase II SBIR contract for wound healing polymers

GelSana Therapeutics was awarded a $1.25 million Phase II SBIR contract by AFWERX to develop novel polymers for enhanced wound healing in combat-related burn injuries. The company will collaborate with Walter Reed Medical Center.

“We are honored to have received this contract from AFWERX to develop our unique polymers for combat-related burn injuries.”gelsanatherapeutics.com

• 1 source
• gelsanatherapeutics.comGelSana Awarded an AFWERX Phase II SBIR Contract to Develop Novel Polymers for Enhanced Wound Healing in Combat-Related Burn Injuries - GelSana Therapeutics, Inc.mdkrebsgelsanatherapeuticscomApr 11, 2024

Summarized from public sources; check the original articles before acting on it.